While CML is characterised by the presence of the Philadelphia chromosome, the BCR-ABL fusion oncogene, AML patients can present with a wide variety of genetic mutations and chromosomal rearrangements. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.